IL37 and type 1 diabetes mellitus: Harms et al. found significantly increased IL-18 expression in the blood and pancreatic tissues of T1D patients, with insufficient compensatory elevation in natural inhibitors such as IL-18BP and IL-37, leading to unregulated pro-inflammatory signaling [119].